| Q35452750 | APOE and mild cognitive impairment: the Framingham Heart Study |
| Q34034409 | APOE and neuroenergetics: an emerging paradigm in Alzheimer's disease |
| Q48486087 | APOE epsilon3 gene transfer attenuates brain damage after experimental stroke |
| Q30499574 | Alzheimer disease models and human neuropathology: similarities and differences |
| Q36546467 | Apolipoprotein (apo) E4 and Alzheimer's disease: unique conformational and biophysical properties of apoE4 can modulate neuropathology |
| Q42869239 | Apolipoprotein E Controls ATP-Binding Cassette Transporters in the Ischemic Brain |
| Q28282855 | Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy |
| Q37060457 | Apolipoprotein E and Alzheimer's disease: molecular mechanisms and therapeutic opportunities. |
| Q37009967 | Apolipoprotein E and cholesterol in aging and disease in the brain |
| Q24604376 | Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy |
| Q41691286 | Apolipoprotein E epsilon 4 (APOE-ε4) genotype is associated with decreased 6-month verbal memory performance after mild traumatic brain injury |
| Q40571686 | Apolipoprotein E4 domain interaction occurs in living neuronal cells as determined by fluorescence resonance energy transfer |
| Q34345696 | Apolipoprotein E4 produced in GABAergic interneurons causes learning and memory deficits in mice |
| Q22248091 | Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease |
| Q34497951 | Apolipoprotein E: From lipid transport to neurobiology |
| Q28265290 | Apolipoprotein E: diversity of cellular origins, structural and biophysical properties, and effects in Alzheimer's disease |
| Q34680878 | Apolipoproteins in the brain: implications for neurological and psychiatric disorders |
| Q45208064 | Astrocytes produce and secrete FGF-1, which promotes the production of apoE-HDL in a manner of autocrine action |
| Q40621541 | Astroglial regulation of apolipoprotein E expression in neuronal cells. Implications for Alzheimer's disease |
| Q37705204 | CSF Apo-E levels associate with cognitive decline and MRI changes |
| Q35978742 | Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer's disease-like neurodegeneration and behavioral deficits in transgenic mice |
| Q35889289 | Comparative Proteomic Analysis of Two Uveitis Models in Lewis Rats |
| Q37731946 | Diet and age interactions with regards to cholesterol regulation and brain pathogenesis |
| Q53217399 | Endogenous Apolipoprotein E (ApoE) Fragmentation Is Linked to Amyloid Pathology in Transgenic Mouse Models of Alzheimer's Disease. |
| Q45923598 | Enriched environment reduces apolipoprotein E (ApoE) in reactive astrocytes and attenuates inflammation of the peri-infarct tissue after experimental stroke. |
| Q24312559 | FGF-1 induces expression of LXRalpha and production of 25-hydroxycholesterol to upregulate the apoE gene in rat astrocytes |
| Q28564153 | FGF-1-induced reactions for biogenesis of apoE-HDL are mediated by src in rat astrocytes |
| Q30497475 | GABAergic interneuron dysfunction impairs hippocampal neurogenesis in adult apolipoprotein E4 knockin mice |
| Q30371094 | Gene sequences regulating the production of apoE and cerebral palsy of variable severity. |
| Q92527442 | Genetic Interaction of APOE and FGF1 is Associated with Memory Impairment and Hippocampal Atrophy in Alzheimer's Disease |
| Q42330123 | Identification of a Nuclear Respiratory Factor 1 Recognition Motif in the Apolipoprotein E Variant APOE4 linked to Alzheimer's Disease |
| Q38657053 | Increased Aβ42-α7-like nicotinic acetylcholine receptor complex level in lymphocytes is associated with apolipoprotein E4-driven Alzheimer's disease pathogenesis |
| Q36847737 | Links between copper and cholesterol in Alzheimer's disease |
| Q34210006 | Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity |
| Q48146859 | Mechanism for FGF-1 to regulate biogenesis of apoE-HDL in astrocytes |
| Q44795511 | Neuron-specific apolipoprotein e4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice. |
| Q36395775 | Pallidal neuronal apolipoprotein E in pantothenate kinase-associated neurodegeneration recapitulates ischemic injury to the globus pallidus |
| Q37636579 | Potential implications of Apolipoprotein E in early brain injury after experimental subarachnoid hemorrhage: Involvement in the modulation of blood-brain barrier integrity |
| Q46529938 | Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus. |
| Q46069993 | Retracted: Advances in the physiological and pathological implications of cholesterol. |
| Q46019370 | Roles of apolipoprotein E4 (ApoE4) in the pathogenesis of Alzheimer's disease: lessons from ApoE mouse models. |
| Q41771621 | Spectroscopic studies of GSK3{beta} phosphorylation of the neuronal tau protein and its interaction with the N-terminal domain of apolipoprotein E. |
| Q48201452 | The Interplay Between Apolipoprotein E4 and the Autophagic-Endocytic-Lysosomal Axis. |
| Q38032676 | The abluminal endothelial membrane in neurovascular remodeling in health and disease |